Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Applied Biochemistry and Biotechnology|October 14, 2025
Saikosaponin D Modulates STAT3 and c-Myc Expression in MDA-MB-231 Cells: A Comprehensive In Silico and In Vitro StudyBhuvaneshwari Deivendran, Suryaa Manoharan, Ekambaram PerumalPhytotherapy Research : PTR|April 8, 2026
A Comprehensive Review on Necroptosis Inducing Phytochemicals for Cancer Therapy: Preclinical EvidenceBhuvaneshwari Deivendran, Suryaa Manoharan, Ekambaram PerumalJournal of Xenobiotics|December 22, 2022
Chemotherapeutic Potential of Saikosaponin D: Experimental EvidenceSuryaa Manoharan, Bhuvaneshwari Deivendran, Ekambaram PerumalMolecular Diversity|December 11, 2025
Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a reviewSuryaa Manoharan, Ekambaram PerumalBioorganic Chemistry|December 8, 2024
Chemotherapeutic potential of radotinib against blood and solid tumors: A beacon of hope in drug repurposingSuryaa Manoharan, Ekambaram PerumalFitoterapia|October 22, 2024
A strategic review of STAT3 signaling inhibition by phytochemicals for cancer prevention and treatment: Advances and insightsSuryaa Manoharan, Ekambaram PerumalEuropean Journal of Pharmacology|October 20, 2022
Potential role of Marine Bioactive Compounds in cancer signaling pathways: A reviewSuryaa Manoharan, Ekambaram PerumalNaunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 2026
An integrative genomic analysis of angiogenesis in hepatocellular carcinoma: from canonical drivers to emerging biomarkersSuryaa Manoharan, Viswaganesh Venkatesan, Ekambaram PerumalFitoterapia|January 3, 2024
Natural bioactive compounds and FOXO3a in cancer therapeutics: An updateSuryaa Manoharan, Kunjkumar Prajapati, Ekambaram PerumalArchiv Der Pharmazie|October 21, 2024
Targeting STAT3, FOXO3a, and Pim-1 kinase by FDA-approved tyrosine kinase inhibitor-Radotinib: An in silico and in vitro approachSuryaa Manoharan, Aksayakeerthana Santhakumar, Ekambaram PerumalPageof 9